A mutated glycosaminoglycan-binding domain functions as a novel probe to selectively target heparin-like epitopes on tumor cells.
Xu Y, Shi L, Qin Y, Yuan X, Wang X, Zhang Q, Wei L, Du M, Liu Y, Yuan M, Xu X, Cheng R, Zou R, Wang W, Li F.
Xu Y, et al. Among authors: yuan x, yuan m.
J Biol Chem. 2022 Dec;298(12):102609. doi: 10.1016/j.jbc.2022.102609. Epub 2022 Oct 17.
J Biol Chem. 2022.
PMID: 36265583
Free PMC article.